Difference between revisions of "Muscularis propria invasion in the urinary bladder"

Jump to navigation Jump to search
 
(4 intermediate revisions by the same user not shown)
Line 7: Line 7:


Staging of bladder cancer is dealt with in the ''[[bladder cancer staging]]'' article.
Staging of bladder cancer is dealt with in the ''[[bladder cancer staging]]'' article.
'''''Muscle invasive bladder cancer''''' redirects to this article and refers to invasion of the ''muscularis propria''. 
''Bladder muscularis propria invasion'' and ''urinary bladder muscularis propria invasion'' redirect to this article.


==General==
==General==
Line 67: Line 71:
Image: Muscle invasive urothelial carcinoma -- high mag.jpg | MIUC - high mag.
Image: Muscle invasive urothelial carcinoma -- high mag.jpg | MIUC - high mag.
</gallery>
</gallery>
==IHC==
''Smoothelin'' [[immunostain]]:<ref name=pmid18936687>{{Cite journal  | last1 = Paner | first1 = GP. | last2 = Shen | first2 = SS. | last3 = Lapetino | first3 = S. | last4 = Venkataraman | first4 = G. | last5 = Barkan | first5 = GA. | last6 = Quek | first6 = ML. | last7 = Ro | first7 = JY. | last8 = Amin | first8 = MB. | title = Diagnostic utility of antibody to smoothelin in the distinction of muscularis propria from muscularis mucosae of the urinary bladder: a potential ancillary tool in the pathologic staging of invasive urothelial carcinoma. | journal = Am J Surg Pathol | volume = 33 | issue = 1 | pages = 91-8 | month = Jan | year = 2009 | doi = 10.1097/PAS.0b013e3181804727 | PMID = 18936687 }}</ref>
*Muscularis propria - usu. strong. †
*Muscularis mucosae - negative/weak. †
Note:
*† Overlap between the patterns is described;<ref name=pmid20154589>{{Cite journal  | last1 = Miyamoto | first1 = H. | last2 = Sharma | first2 = RB. | last3 = Illei | first3 = PB. | last4 = Epstein | first4 = JI. | title = Pitfalls in the use of smoothelin to identify muscularis propria invasion by urothelial carcinoma. | journal = Am J Surg Pathol | volume = 34 | issue = 3 | pages = 418-22 | month = Mar | year = 2010 | doi = 10.1097/PAS.0b013e3181ce5066 | PMID = 20154589 }}</ref> this limits the utility of the immunostain.
**Immunostain '''not''' used in many practice environments.


==Sign out==
==Sign out==
48,474

edits

Navigation menu